Evidence map›Paper›PMID 35089504›Full record

ReviewNeurochemical research2022

In Vivo

Pravat K Mandal, Rimil Guha Roy, Avantika Samkaria, Joseph C Maroon, Yashika Arora

Abstract readReview
PubMed Publisher
In one paragraph

Review in Neurochemical research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Observational
  7. Candidate biomarkers in psychiatric disorders: state of the field.World psychiatry : official journal of the World Psychiatric Association (WPA) · 2023
    Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Pravat K MandalNeuroimaging and Neurospectroscopy (NINS) Laboratory, National Brain Research Centre (NBRC), Gurgaon, India. pravat.mandal@gmail.com.ORCID http://orcid.org/0000-0003-4999-2808
Rimil Guha Roy *Neuroimaging and Neurospectroscopy (NINS) Laboratory, National Brain Research Centre (NBRC), Gurgaon, India.
Avantika Samkaria *Neuroimaging and Neurospectroscopy (NINS) Laboratory, National Brain Research Centre (NBRC), Gurgaon, India.
Joseph C MaroonDepartment of Neurosurgery, University of Pittsburgh Medical School, Pittsburgh, PA, USA.
Yashika AroraNeuroimaging and Neurospectroscopy (NINS) Laboratory, National Brain Research Centre (NBRC), Gurgaon, India.
National Brain Research Centre · INFlorey Institute of Neuroscience and Mental Health · AUUniversity of Pittsburgh · US

Funding

Department of Biotechnology , Ministry of Science and Technology BT/2016
6 · The paper itself

Abstract

Magnetic resonance spectroscopy (MRS) is a non-invasive technique that contributes to the elucidation of brain biochemistry.

Indexed as

Alzheimer DiseaseGlutamic AcidBrainGlutamineHumansMagnetic Resonance ImagingMagnetic Resonance SpectroscopyGlutamic AcidGlutamineBrainBrain diseasesCarbon-13Magnetic resonance spectroscopyMetabolic fluxMethodology development

Identifiers

PMID35089504
OpenAlexW4210322019

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.